Gold Bond Intensive Relief Anti-Itch

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Gold Bond Intensive Relief Anti-Itch
Generic name: PRAMOXINE HYDROCHLORIDE, MENTHOL
Manufacturer: Chattem, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: e5a3f8d4-b3d8-4b88-b9a9-833406d3e6f8
SPL ID: 081ef785-fe00-4339-8aa6-c93b44f076e8
Version: 4
Effective date: 2026-01-14
Source export date: 2026-10-12
Source partition: 2
Source file: https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/4760f38f2bcb10aa20ddbadb42b270d31e9f2a8024440d3af3dec8d11feb92ec/drug-label-0002-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:28:12

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Gold Bond Intensive Relief Anti-Itch	openfda.brand_name
generic name		PRAMOXINE HYDROCHLORIDE, MENTHOL	openfda.generic_name
manufacturer name		Chattem, Inc.	openfda.manufacturer_name
ndc	package	41167-0507-0	openfda.package_ndc
ndc	product	41167-0507	openfda.product_ndc
ndc11	package	41167050700	derived:openfda.package_ndc
rxcui		1293905	openfda.rxcui
spl id		081ef785-fe00-4339-8aa6-c93b44f076e8	id
spl set id		e5a3f8d4-b3d8-4b88-b9a9-833406d3e6f8	set_id
unii		L7T10EIP3A	openfda.unii
unii		88AYB867L5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product ■ avoid contact with eyes Stop use and ask a doctor if ■ condition worsens ■ symptoms persist for more than 7 days or clear up and occur again within a few days Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.